Retail, Tech Earnings, and Berkshire’s Surprising Buys
Motley Fool Money
00:00
Investing Insights & Nostalgia
The hosts connect with their audience through a Q&A session, reflecting on past stock predictions while addressing the balance of selling successful stocks. They analyze two biotech companies, discussing their challenges and growth prospects, especially focusing on the current situation of Bluebird Bio and the potential of RadNet.
Play episode from 31:23
Transcript
